1. Novartis Ag (17 from 3,923 patents)

2. Novartis Vaccines & Diagnostics, Gmbh (8 from 245 patents)

1. 10709712 - Biaryl amide compounds as kinase inhibitors

2. 10392404 - Compounds and compositions as kinase inhibitors

3. 10245267 - Biaryl amide compounds as kinase inhibitors

4. 9694016 - Biaryl amide compounds as kinase inhibitors

5. 9498540 - Cell proliferation inhibitors and conjugates thereof

6. 9242969 - Biaryl amide compounds as kinase inhibitors

7. 8778951 - Heteroaryl compounds and their uses

8. 8748626 - Oxazole and thiazole compounds as KSP inhibitors

9. 8735599 - Substituted imidazole derivates

10. 8664256 - Kinesin inhibitors as cancer therapeutics

11. 8563549 - Pyrimidine derivatives used as PI-3 kinase inhibitors

12. 8546434 - Triazole compounds as KSP inhibitors

13. 8415381 - Heteroaryl compounds and their uses

14. 8318791 - Substituted imidazole derivatives

15. 8252832 - Kinesin inhibitors as cancer therapeutics